Tag Archives: Ranitidine

Recalled Zantac OTC Brand Return To Market With Generic Pepcid Ingredient

April 29, 2021 By: Irvin Jackson
Zantac Lawsuit Filed in California State Court Over Breast Cancer Risk

April 27, 2021 By: Irvin Jackson
Increased Risk of Bladder Cancer From Zantac Seen in New Study

April 21, 2021 By: Irvin Jackson
Following Zantac Problems and Recalls, GlaxoSmithKline Sells Manufacturing Plant In India For Fraction Of Value

April 05, 2021 By: Irvin Jackson
Amended Class Action Lawsuits Over Zantac Recalls Filed in MDL

March 01, 2021 By: Irvin Jackson
Zantac Risks Inherent in Heartburn Drug, Producing Cancer-Causing Chemical in Human Body: Study

February 19, 2021 By: Irvin Jackson
Types of Cancer Linked to Zantac That Will Be Supported By Export Reports Outlined By Plaintiffs Leadership in MDL

January 12, 2021 By: Irvin Jackson
Cancer Risk from Zantac Continues to Come As Surprise To Former Users of Recalled Drug

November 20, 2020 By: Irvin Jackson
Generic Manufacturers and Repackagers Seek To Dismiss Ranitidine Class Action Lawsuits

November 11, 2020 By: Irvin Jackson
Zantac Cancer Cases Continue To Be Diagnosed Over A Year After Drug Recall

November 05, 2020 By: Irvin Jackson

Lawyers in Hair Relaxer Cancer Lawsuits Fail To Reach Agreement on Bellwether Plan (Posted 5 days ago)

Judge presiding over all federal hair relaxer lawsuits has ordered the parties to submit separate briefing on the bellwether selection process by January 3.

Depo-Provera Lawsuit MDL Application Will Be Considered by JPML at Hearing on Jan. 30, 2025 (Posted 6 days ago)

With a growing number of women pursuing Depo-Provera brain tumor lawsuits throughout the federal court system, the U.S. JPML will decide whether to consolidate and centralize the claims before one judge for coordinated discovery and pretrial proceedings.

AngioDynamics Port Catheter Lawyers Seek Leadership Roles in MDL (Posted 7 days ago)

A proposal has been submitted for a group of 12 lawyers involved in AngioDynamics port catheter lawsuits to serve in various leadership positions in the litigation, which involves dozens of claims that the implants were defectively designed, leading to fractures, migration and infections.

Tag Archives: Ranitidine

Recalled Zantac OTC Brand Return To Market With Generic Pepcid Ingredient

Zantac Lawsuit Filed in California State Court Over Breast Cancer Risk

Increased Risk of Bladder Cancer From Zantac Seen in New Study

Following Zantac Problems and Recalls, GlaxoSmithKline Sells Manufacturing Plant In India For Fraction Of Value

Amended Class Action Lawsuits Over Zantac Recalls Filed in MDL

Zantac Risks Inherent in Heartburn Drug, Producing Cancer-Causing Chemical in Human Body: Study

Types of Cancer Linked to Zantac That Will Be Supported By Export Reports Outlined By Plaintiffs Leadership in MDL

Cancer Risk from Zantac Continues to Come As Surprise To Former Users of Recalled Drug

Generic Manufacturers and Repackagers Seek To Dismiss Ranitidine Class Action Lawsuits

Zantac Cancer Cases Continue To Be Diagnosed Over A Year After Drug Recall

More Top Stories

Review A Case